Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing end-tidal sevoflurane in cirrhotic vs non-cirrhotic patients undergoing major hepatic resection
TCTR20170929002Active, not recruiting
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sevoflurane in Cirrhosis and hepatic neoplasm (2 arms), sponsored by none. Primary endpoint: End-tidal sevoflurane concentration. Started Sep 2017; status: active, not recruiting.
02
Drugs
sevoflurane
03
Conditions
Cirrhosishepatic neoplasm
Beyond the preview
Go deeper on TCTR20170929002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170929002.